Pentoxifylline
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00806 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 19 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | ischemic disease | KG + DL |
| 2 | intracranial arteriosclerosis | KG + DL |
| 3 | vascular ectasia | KG + DL |
| 4 | Monckeberg arteriosclerosis | KG + DL |
| 5 | angiodysplasia | KG + DL |
| 6 | priapism | KG + DL |
| 7 | fibrocartilaginous embolism | KG + DL |
| 8 | venous thromboembolism | KG + DL |
| 9 | non-inflammatory vasculopathy | KG + DL |
| 10 | congenital renal artery stenosis | KG + DL |
| 11 | rheumatoid arthritis | KG + DL |
| 12 | livedo reticularis | KG + DL |
| 13 | May-Thurner syndrome | KG + DL |
| 14 | mesenteric vascular occlusion | KG + DL |
| 15 | trigeminal autonomic cephalalgia | KG + DL |
| 16 | vascular insufficiency disorder | KG + DL |
| 17 | headache disorder | KG + DL |
| 18 | bronchitis | KG + DL |
| 19 | erythromelalgia | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.